(Q39676593)

English

Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).

scientific article published on February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM). (English)

1 reference

Europe PubMed Central

13 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Roobol MJ

1

1 reference

Europe PubMed Central

13 September 2017

Kranse R

2

1 reference

Europe PubMed Central

13 September 2017

de Koning HJ

3

1 reference

Europe PubMed Central

13 September 2017

Schröder FH

4

1 reference

Europe PubMed Central

13 September 2017

language of work or name

0 references

publication date

1 February 2004

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

63

1 reference

Europe PubMed Central

13 September 2017

2

1 reference

Europe PubMed Central

13 September 2017

309-13; discussion 313-5

1 reference

Europe PubMed Central

13 September 2017

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.083

7 January 2021

Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.083

7 January 2021

Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam).

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.083

7 January 2021

Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.083

7 January 2021

PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.083

7 January 2021

Parameterization of multivariate random effects models for categorical data

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.083

7 January 2021

Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.083

7 January 2021

Lowering PSA cutoffs to enhance detection of curable prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.083

7 January 2021

Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.083

7 January 2021

Identifiers

10.1016/J.UROLOGY.2003.09.083

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39676593&oldid=1521698155"